Endometrial Endometrioid Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Endometrioid Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers [Phase 1, Phase 2]
Clinical trial update exploring addition of the AKT inhibitor ipatasertib to megestrol acetate for recurrent or metastatic endometrial cance…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
A clinical trial update notes a study on predicting recurrence in low-risk endometrial cancer patients with FIGO grade 1–2 endometrioid aden…